Skin Cancer

Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.

A week of surfing at cancer camp.

The House of Representatives just passed the 21st Century Cures Act, providing over $6 billion for health initiatives.

Six-year breast cancer survivor is still unhappy with brain fog, even this far out from chemotherapy treatments.

A combination of topical drugs may reduce lesions that eventually grow into cancer, according to a recent study.

A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.

Immunotherapy continues to advance in melanoma and other solid tumor types as new combinations and biomarkers are being explored.

Here are some tips to make the holiday season go more smoothly.

A recent study outlined both the risks and benefits of sun exposure. Authors say that sensible sun exposure (without getting sun burn) may actually decrease a person's risk of getting melanoma.

Breast cancer and melanoma survivors shares thoughts to fight cancer fatigue from a book by Christiane Northrup, M.D.

Intratumoral SD-101 and Keytruda proved to be well-tolerated for patients with early stage melanoma, according to the results of a recent study.

Breast cancer and melanoma survivor gets out of her thoughts by getting outdoors and re-prioritizing her life.

A cancer diagnosis comes served up with a slew of side effects. While many can be anticipated and managed, some cannot. They can crop up unexpectedly and take up residence indefinitely.

Many patients with melanoma develop a resistance to targeted therapy, but new options to prevent resistance are being explored.

Clutter clearing speaker/author turned two-time cancer survivor shares her holiday tips.

According to a recent trial, an immunotherapy combination was shown to be effective in high-risk melanoma. But because of the high toxicity profile, more research is needed.

A six-year breast cancer survivor and three-year melanoma survivor reflects back and offers hope.

In an interview with CURE, James Allison, Ph.D. talks about the progress immunotherapy has made, as well as potential combinations with immunotherapy and other treatment types to provide better outcomes for patients.

Breast cancer and melanoma survivor finds herself waiting for results again.

CURE spoke with expert Jason Luke about updates and future prospects for immunotherapy in melanoma.

Do I want to be asked how I am doing? A six year breast cancer and three-year melanoma survivor ponders this question.

A two-time cancer survivor shares her experiences with cancer's side effects.

Yervoy reduced risk of death for patients with high-risk stage 3 melanoma in a recent study.

A new drug combination showed improved progression-free survival for patients with advanced melanoma, according to a recent study.